Aegea Medical said last week it tapped former Cardiokinetix prez & CEO Maria Sainz as its new president and chief executive officer, effective immediately. Sainz will replace former CEO Don Gurskis, who has held the corner office since 2013. Gurskis will remain on as member of the Redwood City, Calif.-based company’s executive management team. “Maria is […]
Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has […]
Halyard Health (NYSE:HYH) said late last month it tapped former Acelity prez & CEO Joseph Woody as its new chief executive officer, replacing a retiring Robert Abernathy. Woody will also assume a seat on the board of directors, with former CEO Abernathy continuing on as board chair, the Alpharetta, Ga.-based company said. “On behalf of the […]
Conventus Orthopaedics said today it closed a $20 million round of financing to support its Conventus Cage implant device designed for 3D fixation and fracture repair. The Conventus Cage is designed to allow for a “less invasive” reliable 3D fixation for treating proximal humerus, distal radius and proximal radius fractures, the company said. The round was […]
Ivenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO. Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury, Mass.-based Ivenix, which raised $42 million last September, is developing an infusion management system for hospitals that will combine an information technology interface […]
Conventus Orthopaedics said today it completed a $23.5 million round of equity financing to support its Conventus Cage device designed for 3D fixation and fracture repair. The round was supported entirely by existing investors, Minneapolis, Minn.-based Conventus said. Funds from the round will be used to support the commercial launch of the Conventus Cage. Funding […]
Conventus Orthopaedics said it raised $21 million out of a hoped-for $23.1 million for its shoulder and wrist fracture repair technology. Minneapolis-based Conventus is developing a nitinol device that’s designed to expand inside the bone as an internal scaffold to prevent collapse of a shoulder fracture. Another Conventus device also uses nitinol to treat distal fractures of […]
Conventus Orthopaedics, with an FDA clearance in hand, plans a gradual rollout of a new device designed to help repair shoulder fractures in a less invasive way.
Conventus Orthopaedics gained FDA clearance for a device that helps repair shoulder fractures, and will pursue a "measured" U.S. market rollout in the weeks ahead, company officials said.